News / Events

— The Current Cytology-Based System and Japan’s Transitional Phase Toward HPV PCR Screening — Introduction Cervical cancer screening in Japan has long been conducted primarily using cytology (Pap smear).While this approach has achieved a certain level of success, growing evidence in recent years has clearly established the causal relationship between HPV infection and the development

The HPV PCR–Based Screening Program Implemented in Australia HPV PCR as the Standard for Cervical Cancer Screening in Advanced Countries — Scientific Evidence Shared by WHO, Australia, the UK, and the Netherlands — HPV PCR–based testing (HPV DNA testing), which directly detects high-risk human papillomavirus—the causal agent of cervical cancer—has higher sensitivity than cytology (Pap

— Learning from Tokyo’s Leadership and Australia’s Experience — Human papillomavirus (HPV) is widely known as the main cause of cervical cancer. However, HPV is also responsible for serious cancers in men, including anal cancer, penile cancer, and oropharyngeal (throat) cancer. HPV is therefore not a women’s health issue alone, but a significant public health